Revised March 2012
- Overexpression of the CHRNA5/A3/B4 genomic cluster in mice increases the sensitivity to nicotine and modifies its reinforcing effects. Gallego X, Molas S, Amador-Arjona A, Marks MJ, Robles N, Murtra P, Armengol L, Fernández-Montes RD, Gratacòs M, Pumarola M, Cabrera R, Maldonado R, Sabrià J, Estivill X, Dierssen M. Amino Acids. 2011 Nov 19. [Epub ahead of print]
- Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior. Cohen BN, Mackey ED, Grady SR, McKinney S, Patzlaff NE, Wageman CR, McIntosh JM, Marks MJ, Lester HA, Drenan RM. Neuroscience. 2011 Nov 4. [Epub ahead of print]
- Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. Nature. 2011 Mar 31;471(7340):597-601.
- Genotype-dependent effects of adolescent nicotine exposure on dopamine functional dynamics in the nucleus accumbens shell in male and female mice: a potential mechanism underlying the gateway effect of nicotine. Dickson PE, Rogers TD, Lester DB, Miller MM, Matta SG, Chesler EJ, Goldowitz D, Blaha CD, Mittleman G. Psychopharmacology (Berl). 2011 Jun;215(4):631-42.
- Nicotine decreases food intake through activation of POMC neurons. Mineur YS, Abizaid A, Rao Y, Salas R, DiLeone RJ, Gündisch D, Diano S, De Biasi M, Horvath TL, Gao XB, Picciotto MR. Science. 2011 Jun 10;332(6035):1330-2.
- Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Tuesta LM, Fowler CD, Kenny PJ. Biochem Pharmacol. 2011 Oct 15;82(8):984-95.
- Intravenous nicotine self-administration and cue-induced reinstatement in mice: effects of nicotine dose, rate of drug infusion and prior instrumental training. Fowler CD, Kenny PJ. Neuropharmacology. 2011 Sep;61(4):687-98.
- Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. Nature. 2011 Mar 31;471(7340):597-601.
- Tobacco dependence, the insular cortex and the hypocretin connection. Kenny PJ. Pharmacol Biochem Behav. 2011 Feb;97(4):700-7.
- Plasticity of prefrontal attention circuitry: upregulated muscarinic excitability in response to decreased nicotinic signaling following deletion of α5 or β2 subunits. Tian MK, Bailey CD, De Biasi M, Picciotto MR, Lambe EK. J Neurosci. 2011 Nov 9;31(45):16458-63.
- Mice lacking the galanin gene show decreased sensitivity to nicotine conditioned place preference. Neugebauer NM, Henehan RM, Hales CA, Picciotto MR. Pharmacol Biochem Behav. 2011 Mar;98(1):87-93.
- Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal. Stoker AK, Olivier B, Markou A. Psychopharmacology (Berl). 2011 Dec 3
- Role of α7- and β4-Containing Nicotinic Acetylcholine Receptors in the Affective and Somatic Aspects of Nicotine Withdrawal: Studies in Knockout Mice. Stoker AK, Olivier B, Markou A. Behav Genet. 2011 Oct 19.
- Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats. D'Souza MS, Markou A. Neuropharmacology. 2011 Dec;61(8):1399-405
- Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine. Levine A, Huang Y, Drisaldi B, Griffin EA Jr, Pollak DD, Xu S, Yin D, Schaffran C, Kandel DB, Kandel ER. Sci Transl Med. 2011 Nov 2;3(107):107ra109.
- Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. Nature. 2011 Mar 31;471(7340):597-601.
- Plasticity of prefrontal attention circuitry: upregulated muscarinic excitability in response to decreased nicotinic signaling following deletion of α5 or β2 subunits. Tian MK, Bailey CD, De Biasi M, Picciotto MR, Lambe EK. J Neurosci. 2011 Nov 9;31(45):16458-63.
- Nicotinic α5 Subunits Drive Developmental Changes in the Activation and Morphology of Prefrontal Cortex Layer VI Neurons. Bailey CD, Alves NC, Nashmi R, De Biasi M, Lambe EK.Biol Psychiatry. 2012 Jan 15;71(2):120-8. Epub 2011 Oct 25.
- Reward, addiction, withdrawal to nicotine. De Biasi M, Dani JA. Annu Rev Neurosci. 2011;34:105-30. Review.
- Promoter Methylation and Tissue-Specific Transcription of the α7 Nicotinic Receptor Gene, CHRNA7. Canastar A, Logel J, Graw S, Finlay-Schultz J, Osborne C, Palionyte M, Drebing C, Plehaty M, Wilson L, Eyeson R, Leonard S. J Mol Neurosci. 2011 Nov 4. [Epub ahead of print]
- Transcriptional Repression of the α7 Nicotinic Acetylcholine Receptor Subunit Gene (CHRNA7) by Activating Protein-2α (AP-2α). Finlay-Schultz J, Canastar A, Short M, El Gazzar M, Coughlan C, Leonard S. J Biol Chem. 2011 Dec 9;286(49):42123-32.
- In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression. Doyle GA, Wang MJ, Chou AD, Oleynick JU, Arnold SE, Buono RJ, Ferraro TN, Berrettini WH. PLoS One. 2011;6(8):e23373.
Attention
Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at
Looking for Treatment?
Use the SAMHSA Treatment Locator or 1-800-662-HELP.
Helpline open during government shutdown
Featured Publication
2010 Strategic Plan
Outlines NIDA’s drug abuse and addiction research strategic priorities for the next 5 years, focusing on prevention, treatment, HIV/AIDS, and other cross-cutting issues.